The official blog of the Lung Institute.

Lung Institute Hosts New COPD Treatment Seminar in Knoxville, Offering Free Consultations

28 Jul 2016
| Under Media, Press | Posted by | 2 Comments
Lung Institute Hosts New COPD Treatment Seminar in Knoxville, Offering Free Consultations

Jack Coleman, Jr., M.D., will present an informative seminar for people with chronic lung diseases, August 9th at the University of Tennessee.

TAMPA, Fla. – August 2, 2016: The Lung Institute will host a seminar at the University of Tennessee in Knoxville on August 9 to inform people with chronic lung diseases on the benefits of stem cell therapy for lung disease. Jack Coleman, Jr., M.D., will lead the presentation, explaining how autologous stem cell therapy helps people with lung disease, including chronic obstructive pulmonary disease (COPD), pulmonary fibrosis and emphysema. After the presentation, seminar participants can receive a free consultation with Dr. Coleman to discuss their candidacy for stem cell therapy for lung diseases.

Dr. Coleman is the medical director of the Lung Institute clinic in Nashville, Tenn. The Lung Institute celebrated its three-year anniversary in May. With five clinics in Nashville, Tampa, Scottsdale, Dallas and Pittsburgh, the Lung Institute has treated over 2,500 patients.

According to a recent white paper, 82 percent of Lung Institute patients who participated in a study reported an improvement in their quality of life after receiving stem cell therapy from the Lung Institute. A portion of those patients received a pulmonary function test, and of those tested, 48 percent saw an improvement of 10 percent or higher in their pulmonary function scores.

COPD is the third-leading cause of death in the United States, claiming around 120,000 lives annually. People who have been diagnosed with COPD often feel stigmatized, and, according to a publication in the Western Journal of Nursing Research, COPD patients, in addition to suffering from a sense of guilt, often feel that they are held responsible for their own illness by others, including healthcare providers. Some believe the stigma associated with COPD has slowed the progress of research for a cure. Traditional treatment options had remained unchanged for several decades, until now. Stem cell therapy for lung disease is perhaps the greatest advancement since the advent of the lung transplant.

If you’re in the Knoxville area, https://lunginstitute.com/event/knoxville/08-09-16/ to register for the seminar on August 9 at 2:00 pm. The seminar is held at the UT Conference Center, located at 600 Henley Street, Knoxville, TN 37902.

About the Lung Institute

The Lung Institute is a leading medical provider of regenerative cellular therapy for lung diseases such as chronic obstructive pulmonary disease (COPD), pulmonary fibrosis and interstitial lung disease in the United States. To date the organization has treated over 2,500 patients, 82 percent of which report an improved quality of life. Founded in 2013 in Tampa, Fla., the Lung Institute currently has clinics in Nashville, Tenn., Scottsdale, Ariz., and Pittsburgh, Pa., and Dallas, Texas. For more information, please visit www.lunginstitute.com or call (800) 382-8095.


  1. PB

    12 months ago

    Dear Rosie,

    COPD affects everyone differently and at different rates, so it’s difficult to know the exact life span of someone with COPD. Even though there’s no cure for COPD, with treatment, many people are able to enjoy an improved quality of life. You can read more about the COPD stages and prognosis by clicking here. We hope this information is helpful, and we wish you the best.

    Kind Regards,

    The Lung Institute

  2. Rosie Munoz

    12 months ago

    What is life span with copd

Your Comment

Your email address will not be published.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.